BriaCell Continues Business and Clinical Operations During COVID-19 Pandemic

NEXT STORY
Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of Directors
PREV STORY
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814

author_avatar
NASDAQ Market News

Pfizer und BioNTech veröffentlichen weitere Daten aus Phase-3-Studie: Bis zu 6 Monate nach zweiter Impfung hohe Wirksamkeit und keine schweren Sicherheitsbedenken des COVID-19-Impfstoffs bestätigt

author_avatar
NASDAQ Market News

Genkyotex Announces Positive Post-Hoc Analysis of PBC Phase 2 Trial and Reports Cash Position at June 30, 2019

author_avatar
NASDAQ Market News